Adding Abilify to antidepressant therapy significantly improved major depressive disorder (MDD) patients' symptoms in a recent study. Researchers added either Abilify or a placebo to the treatment regimens of MDD patients who did not have an adequate response to antidepressants alone. The results showed that patients who were given Abilify improved their scores on a depression rating scale more than those who were given a placebo.
Read moreOne of the essential elements of medical treatment is that the patient takes their medication. Why then do so many people choose not to... Read more »
The answer to this question is that they just might, especially if you are taking a certain type of antidepressant. Of course there... Read more »
The other day, I took an impromptu break at work to buy something to drink. "I'm just so dehydrated," I told my boss. "My blood pressure... Read more »
A question from Annie on OurAlzheimer's posed a very interesting and disturbing question; "What can be suggested for anyone who no longer... Read more »
A recent article from the Associated Press reported on the results of a major, 12 year study on women and heart disease. The study... Read more »
A new study has added a new twist to the debate about the link between antidepressants and suicide. Researchers in Finland have found that drugs like... Read more »
Drugmaker Wyeth has reported that the launch of its new experimental antidepressant, DVS-233, has been moved to 2007 following reports of nausea in... Read more »
The U.S. Food and Drug Administration has released a report confirming the link, originally reported in 2004, that using antidepressants slightly... Read more »
A new report has found that 52.3 percent of newly diagnosed bipolar disorder (BPD) patients are prescribed antidepressants as a first-line treatment,... Read more »
Data from a new report shows that between 1996 and 2005, antidepressant use among residents of the United States nearly doubled. Overall, 10.12... Read more »